Aseptika Limited began developing Activ8rlives in 2010 and is currently developing its third generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs), the systems currently focus on respiratory and cardiovascular disease, diabetes, cancer, promoting physical activity and weight management. Aseptika joined the Spirit family of companies in October 2016.
Spirit Healthcare launched in 2009 and provides a range of products and services across several specialisms, including diabetes monitoring devices, structured diabetes education, ambulatory photodynamic therapy to treat non-melanoma skin cancers and cloud-based self-management of Chronic Obstructive Pulmonary Disease (COPD), heart failure and diabetes.
The following positions are currently available with Aseptika Ltd: